
### [NCIT:C7896](http://purl.obolibrary.org/obo/NCIT_C7896)
**Label:** Stage I Bladder Cancer

**Subclasses:** [NCIT:C8904](http://purl.obolibrary.org/obo/NCIT_C8904) (Stage I Squamous Cell Carcinoma of the Bladder), [NCIT:C6191](http://purl.obolibrary.org/obo/NCIT_C6191) (Stage I Bladder Urothelial Carcinoma), [NCIT:C8901](http://purl.obolibrary.org/obo/NCIT_C8901) (Stage I Bladder Cancer without Carcinoma In Situ), [NCIT:C8899](http://purl.obolibrary.org/obo/NCIT_C8899) (Stage I Bladder Cancer with Carcinoma In Situ), [NCIT:C8895](http://purl.obolibrary.org/obo/NCIT_C8895) (Stage I Bladder Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C27966](http://purl.obolibrary.org/obo/NCIT_C27966) (Stage I) 54.17%
- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40388](http://purl.obolibrary.org/obo/NCIT_C40388) (Periductal Breast Myoepitheliosis))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40384](http://purl.obolibrary.org/obo/NCIT_C40384) (Breast Ductal Adenoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40383](http://purl.obolibrary.org/obo/NCIT_C40383) (Breast Apocrine Adenoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 39.52%


